Free provider profile

MAY ABDO-MATKIWSKY, D.O.

NPI 1306887708
Individual
Internal Medicine, Hematology & Oncology
Active registration
Save to rep workspaceFollow this provider Sign in to find emailNPI registry

Need more providers like MAY ABDO-MATKIWSKY?

See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.

Rep intel

What MAY ABDO-MATKIWSKY prescribes and who else does

Top Medicare Part D drugs by claims (public CMS data):

  • Eliquis
  • Pomalyst
  • Jakafi
  • Revlimid
  • Venclexta

See all hematologist-oncologists in NJ who bill Medicare →

Your next referral list starts here

Provider + market indicator

A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.

Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.

Practice contact card

Practice phone

973-726-0005

Fax

973-726-4668

Practice address

89 SPARTA AVE SUITE 130, SPARTA, NJ, 07871

Registry updated
2013-04-18
NPI issued
2006-06-09
RepVector retrieved
11/20/2026

A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.

Registry record

Source: CMS NPPES registry.

89 SPARTA AVE SUITE 130, SPARTA, NJ, 07871

973-726-0005

Single practice location

Enumerated 2006-06-09

  • — Registration is active in NPPES.
  • — Individual clinician record — reachable, but usually not the buyer.
  • — Practice phone number is published.
  • — Full street address on file for route planning.
  • — Record last updated 13 years ago.

Medicare Part D prescribing

Source: CMS Medicare Part D Prescribers by Provider, most recent public year.

Part D claims

2,542

Medicare patients

461

Part D drug cost

$4,434,007

Brand-name share

23.1%

of this prescriber's Part D claims

DrugClaimsMedicare cost
Pomalyst (Pomalidomide)39$858,826
Jakafi (Ruxolitinib Phosphate)36$784,406
Imbruvica (Ibrutinib)12$389,660
Revlimid (Lenalidomide)18$311,734
Lenvima (Lenvatinib Mesylate)12$295,133
Orserdu (Elacestrant Hcl)11$253,445
Eliquis (Apixaban)238$186,224
Venclexta (Venetoclax)15$179,071

Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.

Latest Medicare Part B billing

CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.

Loading the latest published CMS billing file…

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

Checking Open Payments…

Industry payments across NJ — which companies pay providers there.

Tailored to Provider research.

Build the provider research list for one county and check the names yourself.

Name the city, county, or state. RepVector selects the datasets that matter for provider research, enriches each target with what its site publishes, and returns a scored list with phones, addresses and named contacts.

Build a provider research list

3 free runs — no card required.